Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MMTEC Inc MTC

Technology Software - Application
Mmtec Inc is a China-based company primarily engaged in asset management services based on platforms. The Company is principally engaged in providing complete suite trading solutions, including fund creation, distribution, custody, trading and settlement services, to help these financial institutions accelerate their integration into overseas markets. The Company's systems include ETN counter... see more

Recent & Breaking News (NDAQ:MTC)

Transcenta Announced Completion of First Patient Dosing in PET-CT Imaging Study of Radionuclide-Labeled CLDN18.2 Antibody

PR Newswire June 1, 2021

Antengene Announces Fifteen Clinical Studies and Results of Selinexor to be Presented at ASCO 2021

PR Newswire June 1, 2021

H-Source Provides Bi-Weekly Status Report

Canada NewsWire June 1, 2021

OLUMIANT® Improved Pain, Physical Function and Morning Joint Stiffness in Rheumatoid Arthritis in Phase 3 Post-Hoc Analyses

PR Newswire June 1, 2021

Taltz® Showed Consistent, Long-Term Improvement in Key Signs and Symptoms of Axial Spondyloarthritis Through Two Years in Phase 3 Study

PR Newswire June 1, 2021

Amgen to Webcast Investor Meeting at ASCO 2021

PR Newswire June 1, 2021

BIOLASE to Present at the Summer Solstice Best Ideas From the Buy Side Conference on June 2, 2021

PR Newswire June 1, 2021

Aurora Cannabis Completes Balance Sheet Restructuring

Canada NewsWire June 1, 2021

Novartis Cosentyx receives FDA approval for treatment of children and adolescents with moderate to severe plaque psoriasis

PR Newswire June 1, 2021

Predictive Health Diagnostics Company's Proprietary Computational Technology Enables Development of Specialty Diagnostic Tests to Improve Patient Care

PR Newswire June 1, 2021

Centhaquine Improved Shock Index, ARDS, MODS, Reduced Blood Lactate Levels, And 8.8% Absolute Reduction In 28-Day All-Cause Mortality

PR Newswire June 1, 2021

Stealth BioTherapeutics Receives Orphan Drug Designation from the European Medicines Agency for Elamipretide for the Treatment of Barth Syndrome

PR Newswire June 1, 2021

FeverWarn Announces Independent Lab Study Results Proving Non-Contact IR Thermometer Accurately Measures Core Body Temperature

PR Newswire June 1, 2021

Avantor® Acquires RIM Bio; Expands Bioproduction Footprint into China

PR Newswire June 1, 2021

LogicBio Therapeutics to Participate in Upcoming Investor Conferences

PR Newswire June 1, 2021

CTI BioPharma Reports First Quarter 2021 Financial Results

PR Newswire June 1, 2021

Quest Diagnostics Completes Acquisition of Mercy's Outreach Laboratory Services Business

PR Newswire June 1, 2021

Halozyme Highlights Data Presentations by Collaborators for Therapies Utilizing ENHANZE® at 2021 American Society of Clinical Oncology (ASCO) Annual Meeting

PR Newswire June 1, 2021

Neurocrine Biosciences to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

PR Newswire June 1, 2021

Servier Highlights Novel Approaches to Treating Cancer at the ASCO and EHA 2021 Annual Meetings

PR Newswire June 1, 2021